Another clinical study consisting of 10 consecutive GBM patients revealed that HER2-specific T cells could stimulate T-cell proliferation and secretion of IFN-gamma and IL-2 in HER2+ autologous GBM cells. This evidence concerns the gene IFNG and glioblastoma.